Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
22.32
-0.03 (-0.13%)
At close: Dec 16, 2025, 4:00 PM EST
21.89
-0.43 (-1.93%)
After-hours: Dec 16, 2025, 6:43 PM EST
Nanobiotix Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Nanobiotix stock has a target of 8.00, which predicts a -64.16% decrease from the current stock price of 22.32.
Price Target: $8.00 (-64.16%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 4, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Nanobiotix is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $12 → $8 | Strong Buy | Maintains | $12 → $8 | -64.16% | Apr 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | -46.24% | Aug 28, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $11 | Buy | Initiates | $11 | -50.72% | Dec 8, 2023 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 6, 2021 |
Financial Forecast
Revenue This Year
33.32M
from -7.19M
Revenue Next Year
78.84M
from 33.32M
Increased by 136.64%
EPS This Year
-0.53
from -1.44
EPS Next Year
-0.06
from -0.53
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 56.8M | 124.1M | ||||
| Avg | 33.3M | 78.8M | ||||
| Low | 22.5M | 14.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 272.5% | ||||
| Avg | - | 136.6% | ||||
| Low | - | -55.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.09 | 1.61 | ||||
| Avg | -0.53 | -0.06 | ||||
| Low | -0.88 | -0.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.